Loyal

Loyal is an early stage company developing drugs to help dogs live longer, healthier lives. We see aging as a disease that is able to be slowed and improved with medicines. Loyal was spun out of Laura Deming’s The Longevity Fund and is well funded by top venture capitalists and angels. We are currently a small team of engineers with both traditional tech (Apple, Github) as well as biotech backgrounds (Neuralink, Coda, 20n). We're working on everything from consumer-facing products (Connect your Dogstagram as part of our citizen-science platform) to developing data and operations pipelines to enable basic research in aging. We recently licensed IP around an epigenetic clock to quantify biological aging in mice, dogs, and humans that we are excited about as well. All in all, there's a lot of room to make a significant impact, while also having a Slack filled with dog pictures.